Dextera Surgical Inc (DXTR) saw its loss widen to $4.48 million, or $0.50 a share for the quarter ended Mar. 31, 2017. In the previous year period, the company reported a loss of $3.03 million, or $0.34 a share. Revenue during the quarter plunged 41.25 percent to $1.11 million from $1.89 million in the previous year period. Gross margin for the quarter stood at negative 18.14 percent as compared to a positive 51.70 percent for the previous year period.
Operating loss for the quarter was $4.34 million, compared with an operating loss of $2.92 million in the previous year period.
“Product sales for the third quarter were approximately $1 million, favorably impacted by the initiation of sales in Spain as well as an uptick in our cardiac products,” said Julian Nikolchev, president and Chief executive officer of Dextera Surgical Inc. “Looking ahead, we see increasing demand for the MicroCutter in both Europe and the United States.”
Disclaimer: Please note that this is an auto-generated article. IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website. For queries contact: [email protected]
